top of page
LUCAS
Ohio
Campaign Materials
COVID-19 Resources
Social Media Toolkit
COVID-19 themed social media post copy. Download
Social Media Graphics
Accompanying COVID-19 themed social media graphics. Download
Campaign 5: Community Choice*
*Wave one communities may choose one of campaigns 1-4 to repeat for campaign 5. Supplemental materials created to support implementation of campaign 5 dissemination plans are provided below.
Distribution Timeline: February 25, 2022 - June 29, 2022
Campaign Material
Description
Link
Online Partner Toolkits
-
Online W1C1: Naloxone-Fentanyl Toolkit including sample content (e.g., social media posts) that can be shared with partners
W1C1: Naloxone-Fentanyl Distribution Toolkit
-
Word document that includes sample campaign materials (e.g., social media posts, partner outreach letter) that can be tailored by the community.
Campaign 4: Stay in MOUD Treatment
Distribution Timeline: June 1, 2021 - December 31, 2021
Target Audience: People with OUD and needed supporters (loved ones, faith-based)
Campaign Material
Description
Link
Distribution Toolkit
-
Includes sample campaign materials (e.g., social media posts) that can be tailored by the community.
Social Media Graphics
-
Carousel graphics (1080 x 1080 pixels)
Campaign 3: MOUD Awareness
Distribution Timeline: October – December, 2020
Target Audience: People with Lived Experience, Community Leaders, and Providers
Campaign Material
Link
Description
MOUD Distribution Toolkit
-
Includes an updated campaign overview and sample campaign materials (e.g., social media posts, op-ed) that can be tailored by the community.
Campaign 2: Stigma
Distribution Timeline: August – October, 2020
Target Audience: People with Lived Experience, Community Leaders, and Providers
Campaign Material
Description
Link
Spanish Materials
-
Social media (SM) graphics for Facebook (1200 x 628 pixels)
-
Posters (11 x 17 inches)
-
Palm cards (4 x 6 inches)
2-sided palm card
-
Palm Card (4x6 inches) in desktop and print versions
Print Materials - Buprenorphine
-
Flyer (8.5x11 inches)
Digital Materials
-
Social media graphics (1200 x 628 pixels)
Stigma Distribution Toolkit
-
Toolkit includes an updated campaign overview and sample copy (e.g., newsletter) that can be tailored by the community.
-
Social media (SM) toolkits include sample copy and graphics in English and Spanish.
Background Fact Sheets
-
Information on MOUD, stigma, and brain changes
MOUD Fact Sheet
-
Provides information about what MOUD is and where to get it.
MOUD Op-Ed
-
Sample copy for an op-ed piece that can be edited by the community
Campaign 1: Naloxone (Narcan®)
Distribution Timeline: April – June, 2020
Other Campaign Materials
Campaign Material
Usage
Link
Webinar - Naloxone
-
Provides an overview of the campaign and available materials.
Naloxone Distribution Toolkit
-
Includes an updated campaign overview and sample campaign materials (e.g., social media posts, sample newsletter copy) that can be tailored by the community.
Sample Copy
-
Sample copy found in the toolkit in a Word document for easier editing.
Target Audience: People with Lived Experience & Community Leaders
Campaign Material
Description
Link
Ask your doctor
-
Palm card (6x4 inches) in professional and desktop print versions
-
Poster (11x17 inches) in professional and desktop print versions
Carry naloxone
-
Palm card (6x4 inches) in professional and desktop print versions
-
Poster (11x17 inches) in professional and desktop print versions
Carry naloxone (Option 2 - Updated 6.30.20)
-
Palm card (6x4 inches) in professional and desktop print versions
-
Poster (11x17 inches) in professional and desktop print versions, with QR code
Bag drop
-
8.5x11 inches, desktop print, prints two cards per sheet
Naloxone Social Media Graphics
-
Graphics to accompany the sample social media posts found in the toolkit.
Target Audience: Healthcare Providers
Campaign Material
Description
Usage
Link
Naloxone Fact Sheet
-
8.5 x 11 inches
-
CMYK color for print
-
Accompany this fact sheet with campaign materials designed to reach POUD
-
Encourage Healthcare Providers to disseminate campaign materials for POUD to their high-risk patients and their loved ones
bottom of page